(PGP) as a potential player, biomarker and therapeutic target in this process.
CXCL8 and the generation and effect of PGP
During inflammation, several factors are produced by various cell types in response to stress, such as chemokines and cytokines. In the early phase of inflammation these mediators attract primarily neutrophils. These neutrophils are the hallmark of acute inflammation and one of the first cellular lines in host defense against injury and infection (7). The chemokine CXCL8 (previously known as IL-8) has been identified as a key player in the recruitment of neutrophils (8) . CXCL8 is one of the best-characterized members of the chemokine family. Production of CXCL8 is not restricted to leukocytes, such as neutrophils and macrophages, and it can also be synthesized by endothelial and epithelial cells and fibroblasts (9) . After secretion at the site of production, CXCL8 diffuses through the tissue and (14) . Although the COPD group only consisted of 5 patients, the detected PGP concentrations in BAL were significantly higher in the COPD patients (363 pg/mL) than control subjects (22 pg/mL). It should be noted however that 2 of 18 control subjects showed PGP levels slightly above the detection limit, while in the COPD patients in 2 of 5 samples PGP concentrations were below the detection limit (14) .
Similar findings were reported for CF patients (12) .
Sputum samples collected within 48h of admission from patients treated in the hospital for CF exacerbation showed a significantly higher level of PGP compared to healthy controls. At discharge the mean PGP level had lowered considerably, but still was 5-fold higher compared to controls (12) .
